These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26320281)

  • 41. US Preventive Services Task Force CT lung cancer screening recommendations: community awareness and perceptions.
    Retrouvey M; Patel Z; Shaves S
    J Am Coll Radiol; 2015 Jan; 12(1):114-5. PubMed ID: 25448062
    [No Abstract]   [Full Text] [Related]  

  • 42. Cancer Screening in Patients with Idiopathic Venous Thromboembolism--a Position Paper of the German Society of Hematology and Oncology Working Group on Hemostasis.
    Matzdorff A; Riess H; Bergmann F; Bisping G; Koschmieder S; Parmentier S; Petrides PE; Sosada M
    Oncol Res Treat; 2015; 38(9):454-8. PubMed ID: 26407062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Executive summary.
    von Karsa L; Patnick J; Segnan N
    Endoscopy; 2012 Sep; 44 Suppl 3():SE1-8. PubMed ID: 23012113
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prostate-specific antigen screening, why have the guidelines changed?
    Sountoulides P; Moutzouris G
    Expert Rev Anticancer Ther; 2014 Nov; 14(11):1277-81. PubMed ID: 25306859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Principles of evidence assessment and methods for reaching recommendations.
    Minozzi S; Armaroli P; Segnan N
    Endoscopy; 2012 Sep; 44 Suppl 3():SE9-14. PubMed ID: 23012125
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Screening, early detection, education, and trends for melanoma: current status (2007-2013) and future directions: Part II. Screening, education, and future directions.
    Mayer JE; Swetter SM; Fu T; Geller AC
    J Am Acad Dermatol; 2014 Oct; 71(4):611.e1-611.e10; quiz 621-2. PubMed ID: 25219717
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Which risk model to use? Clinical implications of the ACS MRI screening guidelines.
    Ozanne EM; Drohan B; Bosinoff P; Semine A; Jellinek M; Cronin C; Millham F; Dowd D; Rourke T; Block C; Hughes KS
    Cancer Epidemiol Biomarkers Prev; 2013 Jan; 22(1):146-9. PubMed ID: 23093547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Screening for cancer: concepts and controversies.
    Gates TJ
    Am Fam Physician; 2014 Nov; 90(9):625-31. PubMed ID: 25368922
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of colonoscopy surveillance guidelines: are we actually adhering to the guidelines?
    Walker AS; Nelson DW; Fowler JJ; Causey MW; Quade S; Johnson EK; Maykel JA; Steele SR
    Am J Surg; 2013 May; 205(5):618-22; discussion 622. PubMed ID: 23592173
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral cancer screening for asymptomatic adults: do the United States Preventive Services Task Force draft guidelines miss the proverbial forest for the trees?
    Edwards PC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2013 Aug; 116(2):131-4. PubMed ID: 23849372
    [No Abstract]   [Full Text] [Related]  

  • 51. Cancer screening in the United States, 2012: A review of current American Cancer Society guidelines and current issues in cancer screening.
    Smith RA; Cokkinides V; Brawley OW
    CA Cancer J Clin; 2012; 62(2):129-42. PubMed ID: 22261986
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Six screening tests for adults: What's recommended? What's controversial?
    Nielsen C
    Cleve Clin J Med; 2014 Nov; 81(11):652-5. PubMed ID: 25368213
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The reality of identifying early oral cancer in the general dental practice.
    McGurk M; Scott SE
    Br Dent J; 2010 Apr; 208(8):347-51. PubMed ID: 20418830
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the consideration of serrated polyps to the interval of colonoscopic surveillance in the NHS Bowel Cancer Screening Programme.
    Pullens B; Dekker E; Ellis AJ; Guy R; Madronal K; Chetty R; East JE
    Colorectal Dis; 2014 Sep; 16(9):O320-6. PubMed ID: 24592946
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening for mouth cancer: the pros and cons of a national programme.
    Brocklehurst PR; Speight PM
    Br Dent J; 2018 Nov; 225(9):815-819. PubMed ID: 30412550
    [TBL] [Abstract][Full Text] [Related]  

  • 56. UK's National Screening Committee endorses digital pathology for cancer screening.
    Mahase E
    BMJ; 2023 Dec; 383():2990. PubMed ID: 38158223
    [No Abstract]   [Full Text] [Related]  

  • 57. UK National Screening Committee Criteria: clarification of two misunderstandings.
    Mackie A
    Eur J Hum Genet; 2017 Jun; 25(7):791. PubMed ID: 28443621
    [No Abstract]   [Full Text] [Related]  

  • 58. UK National Screening Committee (NSC) – oral cancer screening in adults.
    Evid Based Dent; 2015 Jun; 16(2):61. PubMed ID: 26320281
    [No Abstract]   [Full Text] [Related]  

  • 59. Summaries for patients. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Ann Intern Med; 2013 May; 158(10):I-28. PubMed ID: 23567761
    [No Abstract]   [Full Text] [Related]  

  • 60. NICE guideline focuses on symptoms to diagnose cancer earlier.
    Mayor S
    Lancet Oncol; 2015 Aug; 16(8):889. PubMed ID: 26143687
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.